Nutex Health (NUTX) CLO logs RSU vesting; 784 shares withheld for taxes

Rhea-AI Filing Summary

Nutex Health Inc. Chief Legal Officer Luqman Elisa V reported routine equity compensation activity involving restricted stock units and common stock. Restricted stock units convert into common stock on a one-for-one basis, and the officer held 4,441 such units following the reported transaction.

Subsequent to vesting, 2,084 common shares were issued, of which 784 shares were delivered to satisfy tax withholding obligations, leaving the remainder as net shares. After these movements, the officer beneficially owned 2,370 common shares, including 2,360 shares held directly and 10 shares held indirectly through a spouse.

Insider Trade Summary

1,525 shares exercised/converted

Mixed 3 txns

Insider Luqman Elisa V

Role Chief Legal Officer - SEC

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	1,525	$0.00	--
Exercise	Common Stock	2,084	$0.00	--
Tax Withholding	Common Stock	784	$86.2224	$68K

Holdings After Transaction: Restricted Stock Units — 4,441 shares (Direct); Common Stock — 3,154 shares (Indirect, See note (4))

Footnotes (1)

1. Restricted stock units convert into common stock on a one-for-one basis. Of the 2,084 shares issued subsequent to vesting, 784 shares were sold to cover tax withholding obligations. On March 11, 2026, the Reporting Person was granted 1,525 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029. The Reporting Person directly owns 2,360 shares. Additionally, the Reporting Person indirectly owns 10 shares through their spouse, resulting in a total beneficial ownership of 2,370 shares.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Luqman Elisa V

(Last) (First) (Middle)

1776 YORKTOWN STREET

SUITE 700

(Street)

HOUSTON TX 77056

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Nutex Health Inc. [ NUTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer - SEC

3. Date of Earliest Transaction (Month/Day/Year)
03/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/10/2026		M		2,084(1)	A	$0(1)	3,154	I	See note (4)(4)
Common Stock	03/10/2026		F		784(2)	D	$86.2224	2,370	I	See note (4)(4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0(1)	03/10/2026		M		1,525(1)		03/01/2027(3)	03/01/2029(3)	Common Stock	1,525	$0	4,441	D

Explanation of Responses:

1. Restricted stock units convert into common stock on a one-for-one basis.

2. Of the 2,084 shares issued subsequent to vesting, 784 shares were sold to cover tax withholding obligations.

3. On March 11, 2026, the Reporting Person was granted 1,525 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.

4. The Reporting Person directly owns 2,360 shares. Additionally, the Reporting Person indirectly owns 10 shares through their spouse, resulting in a total beneficial ownership of 2,370 shares.

	/s/ Elisa Luqman	03/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Nutex Health (NUTX) report for Luqman Elisa V?

Nutex Health reported that Chief Legal Officer Luqman Elisa V had restricted stock units vest into common stock, with shares issued and a portion withheld to cover tax obligations as part of routine equity compensation.

How many Nutex Health shares were issued and withheld for taxes in this Form 4?

A total of 2,084 Nutex Health common shares were issued after restricted stock unit vesting, and 784 of those shares were delivered to cover tax withholding obligations, leaving the remaining shares as net equity for the reporting person.

What is Luqman Elisa V’s beneficial ownership in Nutex Health after this filing?

After the reported transactions, Luqman Elisa V beneficially owned 2,370 Nutex Health common shares, consisting of 2,360 shares held directly and 10 shares held indirectly through a spouse, according to the ownership disclosure footnote.

How do the restricted stock units reported by Nutex Health (NUTX) convert to common stock?

The restricted stock units convert into Nutex Health common stock on a one-for-one basis, meaning each restricted stock unit represents the right to receive one share of common stock upon vesting, as specified in the footnotes of the insider filing.

Were the Nutex Health shares in this Form 4 an open-market purchase or sale?

The transactions were not open-market trades. Shares were issued upon restricted stock unit vesting, and 784 shares were disposed of solely to satisfy tax withholding obligations, which is a standard, non-market mechanism tied to equity compensation.

What role does Luqman Elisa V hold at Nutex Health (NUTX) in this insider report?

In this insider report, Luqman Elisa V is identified as an officer of Nutex Health, serving as Chief Legal Officer – SEC, and the reported transactions relate to their equity-based compensation and associated tax withholding.